
    
      This is a phase I/II study which will evaluate the complication rates, local control,
      cosmetic results, and quality of life of single fraction high gradient partial breast
      irradiation (HG-PBI) when used as the sole method of radiation therapy for patients with
      pathologic stage 0 (=< 2 cm) or I carcinoma of the breast treated with partial mastectomy
      with histologically assessed negative surgical margins.
    
  